Novo Nordisk ADR

NVONYSE · USD
38.20USD-0.51 (-1.33%)
1095

Novo Nordisk ADR (NVO) Wheel Strategy

NVO wheel strategy scan found 110 cash-secured put setups on the previous trading day. Probability of expiring worthless is above 50%. Annualized returns reach up to 100.7%.

Read more

Running a NVO wheel strategy lets you generate consistent premium income on Novo Nordisk ADR while setting your own entry and exit prices on the underlying. Novo Nordisk ADR's wheel combines cash-secured puts and covered calls into a repeatable cycle: sell puts at strikes where you'd be happy to own NVO, and if assigned, sell calls at strikes where you'd be happy to sell. Use our scanner to find the best NVO wheel strategy setups in real time.

The wheel works best on liquid, high-quality names with stable fundamentals and active options markets — exactly the profile many large-cap leaders fit. The mechanics are simple: sell a cash-secured put on NVO, collect premium, and either keep the premium if it expires worthless or take assignment at a discount to current price. Once assigned, sell covered calls against the shares to keep collecting premium until they're called away. Choosing the right strikes, expirations, and IV environment is what separates a profitable NVO wheel from a losing one.

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides insulin pens, growth hormone pens, and injection needles.

In addition, it offers smart solutions for diabetes treatment, such as smart insulin pens and Dose Check, an insulin dose guidance application. The company has a collaboration agreement with UNICEF to tackle childhood obesity; and with Valo Health, Inc. to discover and develop novel drug programmes for cardiometabolic space. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark.

The difference between a wheel that compounds and one that bleeds comes down to strike selection, IV timing, and discipline on assignment. Our scanner handles the heavy lifting: it ranks every leg of the NVO wheel strategy by delta, premium yield, IV rank, and days to expiration, so you can deploy capital where the math works. Build your NVO wheel strategy on data, not gut feel — and let the options wheel do what it does best: pay you to wait.

Oct 2, 202638.50$0.39$0.43-0.4343%56.8%100.7%753
Oct 9, 202638.50$0.66$0.72-0.44113%53.9%61.6%136
Oct 2, 202638.00$0.22$0.24-0.2843%72.1%56.4%2,747
Oct 16, 202638.50$0.85$0.91-0.44183%52.9%47.7%522
Nov 6, 202638.00$1.44$1.80-0.41393%56.9%44.3%40
Oct 9, 202638.00$0.46$0.51-0.35113%63.4%44.1%716
Oct 16, 202638.00$0.64$0.69-0.37183%60.4%36.6%1,750
Oct 23, 202638.00$0.79$0.91-0.38253%58.7%35.0%836
Oct 30, 202638.00$0.98$1.02-0.39323%57.7%30.6%807
Nov 20, 202637.50$1.46$1.62-0.37533%60.2%29.8%11,652

As of September 28, 2026

Run the Wheel on NVO With Confidence

Find the best NVO wheel strategy setups across strikes and expirations, plan ahead with at-strike values, and keep your covered calls and puts on track.

Start your 14-day free trial